Adicet Bio

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell Adicet Bio and other ETFs, options, and stocks.

About ACET

Adicet Bio, Inc. is a biotechnology company, which engages in the design and development of off-the-shelf allogeneic gamma delta T cell therapies for cancer and other diseases. The company was founded by Aya Jakobovits in November 2014 and is headquartered in Boston, MA.

CEO

Chen Schor

CEOChen Schor

Employees

Employees86

Headquarters

Boston, Massachusetts

HeadquartersBoston, Massachusetts

Founded

2014

Founded2014

Employees

Employees86

ACET Key Statistics

Market cap

557.23M

Market cap557.23M

Price-Earnings ratio

—

Price-Earnings ratio—

Dividend yield

—

Dividend yield—

Average volume

922.67K

Average volume922.67K

High today

$13.95

High today$13.95

Low today

$13.08

Low today$13.08

Open price

$13.40

Open price$13.40

Volume

683.92K

Volume683.92K

52 Week high

$21.17

52 Week high$21.17

52 Week low

$7.13

52 Week low$7.13

Analyst ratings

100%

of 10 ratings

Buy

100%

Hold

Sell

ACET Earnings

-$0.82

-$0.51

-$0.21

$0.10

Q4 FY20

Q1 FY21

Q2 FY21

Q3 FY21

Q4 FY21

Q1 FY22

Q2 FY22

Q3 FY22

Estimated

— per share

Estimated— per share

Actual

Expected Nov 9, After Hours

ActualExpected Nov 9, After Hours

Adicet Bio

Why Robinhood?

Adicet Bio, Inc. is a biotechnology company, which engages in the design and development of off-the-shelf allogeneic gamma delta T cell therapies for cancer and other diseases. The company was founded by Aya Jakobovits in November 2014 and is headquartered in Boston, MA. Show more

ACET Key Statistics

Analyst ratings

100%

Adicet Bio, Inc. is a biotechnology company, which engages in the design and development of off-the-shelf allogeneic gamma delta T cell therapies for cancer and other diseases. The company was founded by Aya Jakobovits in November 2014 and is headquartered in Boston, MA.